Table 1.
Demographics and clinical characteristics.
| LUR80/160-LUR |
PBO-LUR |
QXR-QXR |
P-value | |
|---|---|---|---|---|
| n = 151 | n = 56 | n = 85 | ||
| Age, mean (SD) | 37.1 (12.3) | 37.5 (11.2) | 38.5(10.1) | 0.847 |
| Gender, n (%) | ||||
| Male | 108 (72%) | 35 (63%) | 52 (61%) | 0.248 |
| Female | 43 (28%) | 21 (38%) | 33 (39%) | |
| Race, n (%) | ||||
| White | 87 (58%) | 32 (57%) | 56 (66%) | 0.500 |
| Black | 22 (15%) | 8 (14%) | 13 (15%) | |
| Asian/other | 35 (23%) | 16 (29%) | 12 (14%) | |
| Pretreatment PANSS total score | 98.0 (10.6) | 96.6 (10.3) | 97.8 (10.6) | 0.685 |
| Mean (SD) | N = 151 | N = 56 | N = 85 | |
| Pretreatment CogState composite score | ||||
| Full analysis sample | − 3.90 (3.41) | − 4.54 (3.48) | − 4.30 (3.62) | 0.467 |
| Mean (SD) | N = 137 | N = 54 | N = 80 | |
| Pretreatment ESS | ||||
| Mean (SD) | 5.80 (4.66) | 5.89 (4.38) | 6.73 (3.92) | 0.304 |
| Pretreatment QWB-SA | ||||
| Mean (SD) | 0.57 (0.19) | 0.58 (0.21) | 0.57 (0.19) | 0.959 |